


Amolyt Pharma annonce la première administration de l’AZP-3601 dans son essai clinique de phase 1

Advent France Biotechnology appoints Geoffroy de Ribains as operating partner

Kymos and Prolytic merge to become Kymos Group, a top pan-European CRO dedicated to innovative pharmaceuticals

Minoryx Therapeutics and Sperogenix Therapeutics enter into exclusive license agreement to develop and commercialize leriglitazone in mainland China, Hong Kong and Macau

PDC*line Pharma doses first patient with high dose in ongoing PDC-LUNG-101 clinical trial

Advanced BioDesign welcomes Prof. Pierre Tambourin to its scientific advisory board

Alaxia breaks new ground with lead compound ALX-009 as virucidal agent

ANS Biotech appoints Dr. Philippe Genne to board of directors
